Cargando…
Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells
Motivation: As ‘omics’ biotechnologies accelerate the capability to contrast a myriad of molecular measurements from a single cell, they also exacerbate current analytical limitations for detecting meaningful single-cell dysregulations. Moreover, mRNA expression alone lacks functional interpretation...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908332/ https://www.ncbi.nlm.nih.gov/pubmed/27307648 http://dx.doi.org/10.1093/bioinformatics/btw248 |
_version_ | 1782437661191962624 |
---|---|
author | Schissler, A. Grant Li, Qike Chen, James L. Kenost, Colleen Achour, Ikbel Billheimer, D. Dean Li, Haiquan Piegorsch, Walter W. Lussier, Yves A. |
author_facet | Schissler, A. Grant Li, Qike Chen, James L. Kenost, Colleen Achour, Ikbel Billheimer, D. Dean Li, Haiquan Piegorsch, Walter W. Lussier, Yves A. |
author_sort | Schissler, A. Grant |
collection | PubMed |
description | Motivation: As ‘omics’ biotechnologies accelerate the capability to contrast a myriad of molecular measurements from a single cell, they also exacerbate current analytical limitations for detecting meaningful single-cell dysregulations. Moreover, mRNA expression alone lacks functional interpretation, limiting opportunities for translation of single-cell transcriptomic insights to precision medicine. Lastly, most single-cell RNA-sequencing analytic approaches are not designed to investigate small populations of cells such as circulating tumor cells shed from solid tumors and isolated from patient blood samples. Results: In response to these characteristics and limitations in current single-cell RNA-sequencing methodology, we introduce an analytic framework that models transcriptome dynamics through the analysis of aggregated cell–cell statistical distances within biomolecular pathways. Cell–cell statistical distances are calculated from pathway mRNA fold changes between two cells. Within an elaborate case study of circulating tumor cells derived from prostate cancer patients, we develop analytic methods of aggregated distances to identify five differentially expressed pathways associated to therapeutic resistance. Our aggregation analyses perform comparably with Gene Set Enrichment Analysis and better than differentially expressed genes followed by gene set enrichment. However, these methods were not designed to inform on differential pathway expression for a single cell. As such, our framework culminates with the novel aggregation method, cell-centric statistics (CCS). CCS quantifies the effect size and significance of differentially expressed pathways for a single cell of interest. Improved rose plots of differentially expressed pathways in each cell highlight the utility of CCS for therapeutic decision-making. Availability and implementation: http://www.lussierlab.org/publications/CCS/ Contact: yves@email.arizona.edu or piegorsch@math.arizona.edu Supplementary information: Supplementary data are available at Bioinformatics online. |
format | Online Article Text |
id | pubmed-4908332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-49083322016-06-17 Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells Schissler, A. Grant Li, Qike Chen, James L. Kenost, Colleen Achour, Ikbel Billheimer, D. Dean Li, Haiquan Piegorsch, Walter W. Lussier, Yves A. Bioinformatics Ismb 2016 Proceedings July 8 to July 12, 2016, Orlando, Florida Motivation: As ‘omics’ biotechnologies accelerate the capability to contrast a myriad of molecular measurements from a single cell, they also exacerbate current analytical limitations for detecting meaningful single-cell dysregulations. Moreover, mRNA expression alone lacks functional interpretation, limiting opportunities for translation of single-cell transcriptomic insights to precision medicine. Lastly, most single-cell RNA-sequencing analytic approaches are not designed to investigate small populations of cells such as circulating tumor cells shed from solid tumors and isolated from patient blood samples. Results: In response to these characteristics and limitations in current single-cell RNA-sequencing methodology, we introduce an analytic framework that models transcriptome dynamics through the analysis of aggregated cell–cell statistical distances within biomolecular pathways. Cell–cell statistical distances are calculated from pathway mRNA fold changes between two cells. Within an elaborate case study of circulating tumor cells derived from prostate cancer patients, we develop analytic methods of aggregated distances to identify five differentially expressed pathways associated to therapeutic resistance. Our aggregation analyses perform comparably with Gene Set Enrichment Analysis and better than differentially expressed genes followed by gene set enrichment. However, these methods were not designed to inform on differential pathway expression for a single cell. As such, our framework culminates with the novel aggregation method, cell-centric statistics (CCS). CCS quantifies the effect size and significance of differentially expressed pathways for a single cell of interest. Improved rose plots of differentially expressed pathways in each cell highlight the utility of CCS for therapeutic decision-making. Availability and implementation: http://www.lussierlab.org/publications/CCS/ Contact: yves@email.arizona.edu or piegorsch@math.arizona.edu Supplementary information: Supplementary data are available at Bioinformatics online. Oxford University Press 2016-06-15 2016-06-11 /pmc/articles/PMC4908332/ /pubmed/27307648 http://dx.doi.org/10.1093/bioinformatics/btw248 Text en © The Author 2016. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Ismb 2016 Proceedings July 8 to July 12, 2016, Orlando, Florida Schissler, A. Grant Li, Qike Chen, James L. Kenost, Colleen Achour, Ikbel Billheimer, D. Dean Li, Haiquan Piegorsch, Walter W. Lussier, Yves A. Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells |
title | Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells |
title_full | Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells |
title_fullStr | Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells |
title_full_unstemmed | Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells |
title_short | Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells |
title_sort | analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells |
topic | Ismb 2016 Proceedings July 8 to July 12, 2016, Orlando, Florida |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908332/ https://www.ncbi.nlm.nih.gov/pubmed/27307648 http://dx.doi.org/10.1093/bioinformatics/btw248 |
work_keys_str_mv | AT schissleragrant analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells AT liqike analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells AT chenjamesl analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells AT kenostcolleen analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells AT achourikbel analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells AT billheimerddean analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells AT lihaiquan analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells AT piegorschwalterw analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells AT lussieryvesa analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells |